Literature DB >> 32302633

Structural identification of a fucose-containing 1,3-β-mannoglucan from Poria cocos and its anti-lung cancer CL1-5 cells migration via inhibition of TGFβR-mediated signaling.

Tung-Yi Lin1, Mei-Kuang Lu2, Chia-Chuan Chang3.   

Abstract

Poria cocos (Polyporacea), is a fungus used in traditional Chinese medicine. A study of the valuable sulfated polysaccharides (SPS) with the structure and pharmaceutical benefits from the mycelial culture conditions of P. cocos was attempted. The SPSs were fractionated by gel filtration chromatography to give a fucose-containing mannoglucan polysaccharide (denoted as FMGP): The main skeleton was a 1,4-α-Man-interlaced-1,3-β-glucan with interlaced 6-O-α-l-fucosyl 1,4-α-Glc and 1,4-α-Gal branches. FMGP dramatically inhibited cell migration in the highly metastatic human lung cancer cell line CL1-5 cells. Mechanistically, FMGP dramatically downregulated the expression of TGFβRI and inhibited phosphorylation of FAK and AKT. Moreover, FMGP reduced the metastasis-related protein, Slug, expression. This is the first paper reporting a branched 1,3-β-mannoglucan from P. cocos and its anti-lung cancer CL1-5 cells migration activities.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer cell migration; Poria cocos polysaccharides; Slug

Mesh:

Substances:

Year:  2020        PMID: 32302633     DOI: 10.1016/j.ijbiomac.2020.04.014

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

Review 1.  Extraction, purification, structure, modification, and biological activity of traditional Chinese medicine polysaccharides: A review.

Authors:  Hongkun Xue; Pengcheng Li; Jiayue Bian; Yuchao Gao; Yumei Sang; Jiaqi Tan
Journal:  Front Nutr       Date:  2022-09-09

2.  Isolation and characterization of an anti-proliferative polysaccharide from the North American fungus Echinodontium tinctorium.

Authors:  Mehreen Zeb; Wai Ming Li; Christian Heiss; Ian Black; Linda E Tackaberry; Hugues B Massicotte; Keith N Egger; Kerry Reimer; Parastoo Azadi; Chow H Lee
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

3.  Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo.

Authors:  Niu Shao; Yao Xiao; Jiaxin Zhang; Yuying Zhu; Shenglong Wang; Suzhen Bao
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.